Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
2.380
-0.370 (-13.45%)
Mar 3, 2025, 4:00 PM EST - Market closed
Autonomix Medical Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Selling, General & Admin | 6.68 | 5.25 | 1.25 | 13.59 |
| Research & Development | 3.87 | 2.23 | 0.75 | 0 |
| Operating Expenses | 10.75 | 7.47 | 1.99 | 13.59 |
| Operating Income | -10.75 | -7.47 | -1.99 | -13.59 |
| Interest Expense | -0.18 | -0.08 | - | -0.22 |
| Interest & Investment Income | 0.33 | 0.13 | - | - |
| Other Non Operating Income (Expenses) | -3.03 | -8 | - | 0.31 |
| EBT Excluding Unusual Items | -13.63 | -15.43 | -1.99 | -13.5 |
| Other Unusual Items | - | - | - | 0.17 |
| Pretax Income | -13.63 | -15.43 | -1.99 | -13.33 |
| Net Income | -13.63 | -15.43 | -1.99 | -13.33 |
| Preferred Dividends & Other Adjustments | - | - | - | -0.49 |
| Net Income to Common | -13.63 | -15.43 | -1.99 | -12.84 |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 0 |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 0 |
| Shares Change (YoY) | 17.62% | 21.65% | 480.20% | - |
| EPS (Basic) | -12.86 | -21.09 | -3.31 | -123.94 |
| EPS (Diluted) | -12.86 | -21.09 | -3.31 | -123.94 |
| Free Cash Flow | -8.05 | -6.67 | -1.85 | -0.39 |
| Free Cash Flow Per Share | -7.59 | -9.12 | -3.08 | -3.74 |
| EBITDA | -10.57 | -7.39 | - | - |
| D&A For EBITDA | 0.18 | 0.08 | - | - |
| EBIT | -10.75 | -7.47 | -1.99 | -13.59 |
Source: S&P Capital IQ. Standard template.
Financial Sources.